These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 23613100

  • 1. The emerging role of tiotropium for patients with asthma.
    Bollmeier SG, Lee SY.
    Ann Pharmacother; 2013 May; 47(5):704-13. PubMed ID: 23613100
    [Abstract] [Full Text] [Related]

  • 2. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM.
    J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250
    [Abstract] [Full Text] [Related]

  • 3. Tiotropium for adults with inadequately controlled persistent asthma.
    Adams KS, Lowe DK.
    Ann Pharmacother; 2013 Jan; 47(1):117-23. PubMed ID: 23324511
    [Abstract] [Full Text] [Related]

  • 4. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
    Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E, BELT Investigators.
    JAMA; 2015 Oct 27; 314(16):1720-30. PubMed ID: 26505596
    [Abstract] [Full Text] [Related]

  • 5. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
    Cole JM, Sheehan AH, Jordan JK.
    Ann Pharmacother; 2012 Dec 27; 46(12):1717-21. PubMed ID: 23170031
    [Abstract] [Full Text] [Related]

  • 6. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 27; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 7. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec 27; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 8. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
    Metzger NL, Kockler DR, Gravatt LA.
    Ann Pharmacother; 2008 Jun 27; 42(6):874-81. PubMed ID: 18430791
    [Abstract] [Full Text] [Related]

  • 9. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul 27; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 10. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.
    Kerstjens HA, Disse B, Schröder-Babo W, Bantje TA, Gahlemann M, Sigmund R, Engel M, van Noord JA.
    J Allergy Clin Immunol; 2011 Aug 27; 128(2):308-14. PubMed ID: 21636120
    [Abstract] [Full Text] [Related]

  • 11. Tiotropium: a new therapeutic option in asthma.
    Novelli F, Costa F, Latorre M, Malagrinò L, Celi A, Vagaggini B, Paggiaro P.
    Monaldi Arch Chest Dis; 2013 Aug 27; 79(3-4):109-15. PubMed ID: 24761528
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response.
    Park HW, Yang MS, Park CS, Kim TB, Moon HB, Min KU, Kim YY, Cho SH.
    Allergy; 2009 May 27; 64(5):778-83. PubMed ID: 19183167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anticholinergics for treatment of asthma.
    Quirce S, Domínguez-Ortega J, Barranco P.
    J Investig Allergol Clin Immunol; 2015 May 27; 25(2):84-93; quiz 94-5. PubMed ID: 25997301
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
    Willson J, Bateman ED, Pavord I, Lloyd A, Krivasi T, Esser D.
    Appl Health Econ Health Policy; 2014 Aug 27; 12(4):447-59. PubMed ID: 24974107
    [Abstract] [Full Text] [Related]

  • 20. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May 27; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.